Report Library
All Reports
2018 Biomedtracker / Datamonitor Healthcare ACC Planner
March 08, 2018
The American College of Cardiology (ACC) 67th Scientific Session will be held in Orlando, FL from 10–12 March 2018.
We have assembled a pre-meeting listing of highlights based on presentation titles and abstracts that were released. To download the conference planner in PDF, click the link at the top of the page.
Like our report? Have any questions or feedback? Please let us know at askanalyst@sagientresearch.com.
For our disclosures, please read the Biomedtracker Research Standards.
We have assembled a pre-meeting listing of highlights based on presentation titles and abstracts that were released. To download the conference planner in PDF, click the link at the top of the page.
Like our report? Have any questions or feedback? Please let us know at askanalyst@sagientresearch.com.
For our disclosures, please read the Biomedtracker Research Standards.
| Indications Covered: |
Acute Coronary Syndrome (ACS)
Acute Decompensated Heart Failure - Reduced Ejection Fraction (Acute HFrEF) Anticoagulation Atrial Fibrillation/Flutter Cardiac Valve Surgery Cardiovascular Disease Chronic Heart Failure - Reduced Ejection Fraction (Chronic HFrEF) Coronary Artery Disease Diabetes Mellitus, Type II Drug Toxicity Dyslipidemia / Hypercholesterolemia Stroke Prevention in Atrial Fibrillation (SPAF) |
Additional Resources:
- Meddevicetracker 2018 JP Morgan Healthcare Conference Medtech Review
- 2018 JP Morgan Conference Review
- Biomedtracker Early 2018 Outlook Report
- Meddevicetracker Early 2018 Outlook Report
- Diabetic Nephropathy/Diabetic Kidney Disease and Diabetes CVOT KOL Interview
- Investigating the Market Potential of Bevyxxa
- Datamonitor Healthcare CV&Met: Venous Thromboembolism (VTE) Disease Coverage
- 2017 Biomedtracker / Meddevicetracker / Datamonitor Healthcare Post-ESC Report
- CANVAS Survey
- 2017 Biomedtracker / Datamonitor Healthcare / Trialtrove Post-ADA Report
- Diabetes CVOTs and Cardiologists Survey
- PCSK9 Inhibitors after FOURIER Survey
- Expected PCSK9 Inhibitor Reimbursement after FOURIER
- 2017 Biomedtracker / Meddevicetracker / Datamonitor Healthcare Post-ACC Report